Stay updated on Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial

Sign up to get notified when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The site footer now shows Revision: v3.6.6, replacing the previous revision. This indicates a minor deployment/version label update.
    Difference
    0.1%
    Check dated 2026-08-31T16:49:16.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The site revision label was updated from v3.6.4 to v3.6.5, indicating a software update to the platform. No study content or user-facing information appears to have changed.
    Difference
    0.0%
    Check dated 2026-08-10T12:33:25.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, signaling a new version of the page and its metadata.
    Difference
    0.0%
    Check dated 2026-07-27T05:52:15.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, indicating a new site build; no study content or critical information appears to be altered.
    Difference
    0.0%
    Check dated 2026-07-05T13:19:40.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The page's revision indicator has been updated from v3.6.0 to v3.6.2. This reflects a metadata update rather than any substantive changes to trial information or content.
    Difference
    0.0%
    Check dated 2026-06-28T08:38:42.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    The page now includes new help/navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and shows 'No longer looking for participants' in recruitment. The 'Intervention / Treatment' header has been changed to 'Intervention/Treatment', and the footer revision updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T23:58:55.000Z thumbnail image

Stay in the know with updates to Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.